WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2025-01-062,686$15.00
$40.29kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2025-01-033,092$14.75
$45.61kSell
Travis Alvin ThompsonCHIEF ACCOUNTING OFFICER2025-01-03159$14.75
$2.35kSell
Nigel CrockettCHIEF BUSINESS OFFICER2025-01-03936$14.75
$13.81kSell
Michael SkynnerCHIEF TECHNOLOGY OFFICER2025-01-03936$14.75
$13.81kSell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2025-01-03239$14.75
$3.53kSell
Alistair MilnesCHIEF OPERATING OFFICER2025-01-03936$14.75
$13.81kSell
Santiago ArroyoCHIEF DEVELOPMENT OFFICER2025-01-024,943$14.09
$69.65kSell
Kevin LeeCHIEF EXECUTIVE OFFICER2025-01-029,038$14.09
$127.35kSell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2025-01-021,879$14.09
$26.48kSell

1 of 6

BCYC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP14.48%9,999,674$148.10MInsider
Baker Bros Advisors LP13.61%9,399,960$139.21MInstitution
Deep Track Capital LP5.14%3,548,001$52.55MInstitution
Fcpm III Services Bv3.39%2,339,961$34.65MInstitution
Ra Capital Management LP3.26%2,253,000$33.37MInstitution
Carolyn Ng2.89%1,998,580$29.60MInsider
Tybourne Capital Management Hk Ltd2.84%1,957,961$29.00MInsider
Armistice Capital LLC2.83%1,956,000$28.97MInstitution
Deborah Harland2.77%1,915,275$28.37MInsider
Svlsf V LLC2.77%1,915,274$28.37MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC57.46%42.54%Net BuyingNet Buying
RCKT55.57%44.43%Net SellingNet Selling
NTLA70.75%29.25%Net SellingNet Selling
GYRE0.98%99.02%Net SellingNet Selling
LQDA43.77%56.23%Net BuyingNet Selling
View Top Biotech Stocks

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 58.57% institutional shareholders, 43.36% Bicycle Therapeutics insiders, and 0.00% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 10.00M shares representing 14.48% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $145.50M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.